SE8303050L - Pepsinliknande enzym fran humana leukocyter, forfarande for enzymets framstellning, samt terapeutiskt medel, innehallande enzymet som aktiv bestandsdel och avsett for behandling av allergisjukdomstillstand, immunkomplex - Google Patents

Pepsinliknande enzym fran humana leukocyter, forfarande for enzymets framstellning, samt terapeutiskt medel, innehallande enzymet som aktiv bestandsdel och avsett for behandling av allergisjukdomstillstand, immunkomplex

Info

Publication number
SE8303050L
SE8303050L SE8303050A SE8303050A SE8303050L SE 8303050 L SE8303050 L SE 8303050L SE 8303050 A SE8303050 A SE 8303050A SE 8303050 A SE8303050 A SE 8303050A SE 8303050 L SE8303050 L SE 8303050L
Authority
SE
Sweden
Prior art keywords
enzymet
summents
enzym
pep
humana
Prior art date
Application number
SE8303050A
Other languages
Unknown language ( )
English (en)
Swedish (sv)
Other versions
SE8303050D0 (sv
Inventor
H Ohnishi
H Kozuzume
Y Suzuki
E Mochida
Original Assignee
Mochida Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharm Co Ltd filed Critical Mochida Pharm Co Ltd
Publication of SE8303050D0 publication Critical patent/SE8303050D0/xx
Publication of SE8303050L publication Critical patent/SE8303050L/

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6478—Aspartic endopeptidases (3.4.23)
    • C12N9/6481—Pepsins (3.4.23.1; 3.4.23.2; 3.4.23.3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SE8303050A 1982-05-31 1983-05-30 Pepsinliknande enzym fran humana leukocyter, forfarande for enzymets framstellning, samt terapeutiskt medel, innehallande enzymet som aktiv bestandsdel och avsett for behandling av allergisjukdomstillstand, immunkomplex SE8303050L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP1982/000213 WO1983004260A1 (fr) 1982-05-31 1982-05-31 Enzyme analogue de la pepsine de leucocyte humain et agent therapeutique contenant cette enzyme en tant qu'ingredient effectif pour le traitement de troubles allergiques, de maladies auto-immunitaires et de tumeurs

Publications (2)

Publication Number Publication Date
SE8303050D0 SE8303050D0 (sv) 1983-05-30
SE8303050L true SE8303050L (sv) 1983-12-01

Family

ID=13762278

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8303050A SE8303050L (sv) 1982-05-31 1983-05-30 Pepsinliknande enzym fran humana leukocyter, forfarande for enzymets framstellning, samt terapeutiskt medel, innehallande enzymet som aktiv bestandsdel och avsett for behandling av allergisjukdomstillstand, immunkomplex

Country Status (11)

Country Link
US (1) US4591504A (fr)
AU (2) AU8459882A (fr)
BE (1) BE896895A (fr)
CA (1) CA1207262A (fr)
DE (1) DE3319360C2 (fr)
FR (1) FR2527630B1 (fr)
GB (1) GB2125046B (fr)
IT (1) IT1172264B (fr)
NL (1) NL8301934A (fr)
SE (1) SE8303050L (fr)
WO (1) WO1983004260A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5995221A (ja) * 1982-11-20 1984-06-01 Mochida Pharmaceut Co Ltd 食細胞機能調節作用を有する医薬組成物
ES2054641T3 (es) * 1987-09-30 1994-08-16 Mucos Emulsions Gmbh Utilizacion de enzimas catabolicas para la preparacion de un medicamento destinado a combatir la inmunodeficiencia adquirida (sida) y sus etapas previas (sla y crs).
ES2038546B1 (es) * 1991-11-08 1994-02-16 Andromaco Lab Procedimiento de obtencion de un producto de naturaleza polipeptidica con actividad inhibidora de la hiperproduccion del factor de necrosis tumoral.
JP2711436B2 (ja) * 1995-02-22 1998-02-10 マルホ株式会社 アレルギー治療剤及びアレルギー対応食品

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2119872A1 (fr) * 1970-12-30 1972-08-11 Kuban Med I Im Krasnoi Armii Produit a base de pepsine,notamment pour le traitement des maladies s'accompagnant d'une insuffisance secretoire de l'estomac
US3796636A (en) * 1972-07-14 1974-03-12 Wilson Pharm & Chem Corp Process for preparing high activity pepsin
US4229540A (en) * 1979-07-02 1980-10-21 Cutter Laboratories, Inc. Hydrolase purified from human plasma

Also Published As

Publication number Publication date
IT8348383A0 (it) 1983-05-27
DE3319360A1 (de) 1983-12-01
NL8301934A (nl) 1983-12-16
GB2125046A (en) 1984-02-29
GB2125046B (en) 1985-08-07
GB8314727D0 (en) 1983-07-06
FR2527630B1 (fr) 1986-07-11
BE896895A (fr) 1983-09-16
WO1983004260A1 (fr) 1983-12-08
SE8303050D0 (sv) 1983-05-30
CA1207262A (fr) 1986-07-08
AU547166B2 (en) 1985-10-10
IT1172264B (it) 1987-06-18
AU1507283A (en) 1984-01-19
DE3319360C2 (de) 1986-10-09
US4591504A (en) 1986-05-27
FR2527630A1 (fr) 1983-12-02
AU8459882A (en) 1983-12-16

Similar Documents

Publication Publication Date Title
Šutovská et al. Possible mechanisms of dose-dependent cough suppressive effect of Althaea officinalis rhamnogalacturonan in guinea pigs test system
HK1040636A1 (en) Therapeutic agent for the suppression of snoring noises
WO1994008551A3 (fr) Procedes et compositions pharmaceutiques destines au traitement des symptomes du rhume
SE8303050D0 (sv) Pepsinliknande enzym fran humana leukocyter, forfarande for enzymets framstellning, samt terapeutiskt medel, innehallande enzymet som aktiv bestandsdel och avsett for behandling av allergisjukdomstillstand, immunkomplex
Wongtim et al. Protease activity in cockroach and basidiomycete allergen extracts
Vance et al. Endocrine and clinical effects of leuprolide in prostatic cancer
RU2110254C1 (ru) Композиция для профилактики и лечения гриппа и орви
CA2292902C (fr) Utilisation de peptide calcitonine lie aux genes dans la prevention et le soulagement de l'asthme et d'affections bronchospasmodiques connexes
WO2016036273A1 (fr) Agent médicamenteux pour la prévention et le traitement d'affections des voies respiratoires
DERZAVIS et al. TOPICAL BACITRACIN THERAPY OF PYOGENIC DERMATOSES: A Clinical Report
US4056614A (en) Immunity depressant medicine
Duffy How much is too much high-dose cytosine arabinoside?
NZ287291A (en) Tri-aryl-substituted alanineamide derivatives, analogues and medicaments
US3287220A (en) Anti-asthmatic composition and methods
JP2547325B2 (ja) アレルギ−性疾患治療用外用剤
Sugio et al. Increase in vascular permeability of rat and guinea pig skin by T-kinin
Tanaka et al. Bell's palsy in children: analysis of clinical findings and course
Campbell et al. High-dose allopurinol modulation of 5-FU toxicity: phase I trial of an outpatient dose schedule
US4238502A (en) Method of treating psychiatric conditions
Middleton Jr et al. Immediate Hypersensitivity: II. Drugs in Clinical Use
RU97115801A (ru) Способ лечения стенозирующих ларинготрахеитов у детей
Takahashi et al. Serum angiotensin converting enzyme activity in human bronchial asthma
CA1329776C (fr) Extraits anti-allergiques
Cleveland CONSECUTIVE HERPES ZOSTER AND VARICELLA, WITH VARICELLA IN A CONTACT
Knott et al. Penicillin sprays and upper respiratory tract infection

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8303050-2

Format of ref document f/p: F